Glaukos (GKOS) Total Current Liabilities (2014 - 2026)
Glaukos (GKOS) reported Total Current Liabilities of $89.4 million for Q1 2026, up 30.48% year-over-year from $68.5 million in Q1 2025, and down 11.71% quarter-over-quarter from $101.3 million in Q4 2025.
Glaukos (GKOS) Total Current Liabilities (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Total Current Liabilities data on file, last reported at $89.4 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $89.4 million, up 30.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $89.4 million (up 30.48% YoY), and the FY2025 annual result was $101.3 million, up 34.81% from the prior year.
- Total Current Liabilities declined to $89.4 million in Q1 2026 per GKOS's latest filing, from $101.3 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $101.3 million in Q4 2025 and troughed at $55.6 million in Q1 2022.
- A 5-year average of $73.0 million and a median of $71.7 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities plunged 83.43% in 2022, then soared 34.81% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $72.4 million in 2022, then gained by 2.29% to $74.0 million in 2023, then grew by 1.5% to $75.1 million in 2024, then surged by 34.81% to $101.3 million in 2025, then declined by 11.71% to $89.4 million in 2026.
- Business Quant data shows GKOS's Total Current Liabilities at $89.4 million in Q1 2026, $101.3 million in Q4 2025, and $87.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Glaukos | 7.55 Bn | 7.45 Bn | 117.23 Mn | 89.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.42 Mn |
| Dec 31, 2025 | 101.28 Mn |
| Sep 30, 2025 | 87.52 Mn |
| Jun 30, 2025 | 79.14 Mn |
| Mar 31, 2025 | 68.53 Mn |
| Dec 31, 2024 | 75.13 Mn |
| Sep 30, 2024 | 71.68 Mn |
| Jun 30, 2024 | 70.08 Mn |
| Mar 31, 2024 | 72.24 Mn |
| Dec 31, 2023 | 74.01 Mn |
| Sep 30, 2023 | 67.15 Mn |
| Jun 30, 2023 | 63.89 Mn |
| Mar 31, 2023 | 62.39 Mn |
| Dec 31, 2022 | 72.36 Mn |
| Sep 30, 2022 | 60.62 Mn |
| Jun 30, 2022 | 69.51 Mn |
| Mar 31, 2022 | 55.60 Mn |
| Dec 31, 2021 | 63.36 Mn |
| Sep 30, 2021 | 63.45 Mn |
| Jun 30, 2021 | 349.48 Mn |